Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Therapeutic approaches to diastolic dysfunction.

Literature DB >> 19602330

Therapeutic approaches to diastolic dysfunction.

Rajesh Janardhanan¹, Akshay S Desai, Scott D Solomon.

Abstract

Progressive abnormalities of passive stiffness or active relaxation of the myocardium that impair ventricular filling during diastole may be an important contributor to the development of heart failure in patients with preserved ejection fraction. In this review, we discuss the epidemiology and pathophysiology of diastolic dysfunction and heart failure with preserved ejection fraction, highlighting potential therapeutic approaches and exploring the limited available evidence base for improving clinical outcomes in patients with these challenging entities.

Entities: Disease Species

Mesh：

Year: 2009 PMID： 19602330 DOI： 10.1007/s11906-009-0048-z

Source DB: PubMed Journal: Curr Hypertens Rep ISSN： 1522-6417 Impact factor: 5.369

61 in total

Review 1. Evaluation and management of diastolic heart failure.

Authors: Brad G Angeja; William Grossman
Journal: Circulation Date: 2003-02-11 Impact factor: 29.690

Review 2. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension.

Authors: Arnfried U Klingbeil; Markus Schneider; Peter Martus; Franz H Messerli; Roland E Schmieder
Journal: Am J Med Date: 2003-07 Impact factor: 4.965

Review 3. Clinical practice. Diastolic heart failure.

Authors: Gerard P Aurigemma; William H Gaasch
Journal: N Engl J Med Date: 2004-09-09 Impact factor: 91.245

Review 4. Role of neurohormonal modulators in heart failure with relatively preserved systolic function.

Authors: Jonathan A Rapp; Mihai Gheorghiade
Journal: Cardiol Clin Date: 2008-02 Impact factor: 2.213

5. Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance.

Authors: J F Setaro; B L Zaret; D S Schulman; H R Black; R Soufer
Journal: Am J Cardiol Date: 1990-10-15 Impact factor: 2.778

6. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

Authors: Marcus D Flather; Marcelo C Shibata; Andrew J S Coats; Dirk J Van Veldhuisen; Aleksandr Parkhomenko; Joszef Borbola; Alain Cohen-Solal; Dan Dumitrascu; Roberto Ferrari; Philippe Lechat; Jordi Soler-Soler; Luigi Tavazzi; Lenka Spinarova; Jiri Toman; Michael Böhm; Stefan D Anker; Simon G Thompson; Philip A Poole-Wilson
Journal: Eur Heart J Date: 2005-01-09 Impact factor: 29.983

7. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.

Authors: Richard B Devereux; Björn Dahlöf; Eva Gerdts; Kurt Boman; Markku S Nieminen; Vasilios Papademetriou; Jens Rokkedal; Katherine E Harris; Jonathan M Edelman; Kristian Wachtell
Journal: Circulation Date: 2004-08-23 Impact factor: 29.690

8. Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure.

Authors: Philip M Mottram; Brian Haluska; Rodel Leano; Diane Cowley; Michael Stowasser; Thomas H Marwick
Journal: Circulation Date: 2004-07-26 Impact factor: 29.690

9. Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus.

Authors: John K Boyer; Srihari Thanigaraj; Kenneth B Schechtman; Julio E Pérez
Journal: Am J Cardiol Date: 2004-04-01 Impact factor: 2.778

Review 10. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.

Authors: K T Weber; C G Brilla
Journal: Circulation Date: 1991-06 Impact factor: 29.690

3 in total

Review 1. Hypertension as a risk factor for heart failure.

Authors: Arun Kannan; Rajesh Janardhanan
Journal: Curr Hypertens Rep Date: 2014-07 Impact factor: 5.369

Review 2. Imaging in hypertensive heart disease.

Authors: Rajesh Janardhanan; Christopher M Kramer
Journal: Expert Rev Cardiovasc Ther Date: 2011-02

3. Increased extracellular volume and altered mechanics are associated with LVH in hypertensive heart disease, not hypertension alone.

Authors: Sujith Kuruvilla; Rajesh Janardhanan; Patrick Antkowiak; Ellen C Keeley; Nebiyu Adenaw; Jeremy Brooks; Frederick H Epstein; Christopher M Kramer; Michael Salerno
Journal: JACC Cardiovasc Imaging Date: 2015-01-07

3 in total